Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Unicycive Therapeutics (UNCY) Shares Issued (2021 - 2024)

Unicycive Therapeutics posted quarterly Shares Issued of -$3.8 million for Q1 2024, down 117.21% on a QoQ basis from $22.2 million in Q4 2021.

Unicycive Therapeutics (UNCY) has 2 years of Shares Issued data on file, last reported at -$3.8 million in Q1 2024.

  • For the quarter ending Q1 2024, Shares Issued changed N/A year-over-year to -$3.8 million; the trailing twelve-month figure through Dec 2025 stood at -$3.8 million (changed N/A YoY), and the FY2025 full-year result was $1.5 million, changed N/A from the prior year.
  • Shares Issued for Q1 2024 stood at -$3.8 million, down from $22.2 million in the prior quarter.
  • Across five years, Shares Issued topped out at $22.2 million in Q4 2021 and bottomed at -$3.8 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 5.40 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 27.00 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 163.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 13.16 Mn
10 Unicycive Therapeutics 181.94 Mn 127.36 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 -3.81 Mn
Mar 31, 2024 -3.81 Mn
Dec 31, 2021 22.15 Mn
Dec 31, 2021 22.15 Mn
Mar 31, 2021 119,000.00
Mar 31, 2021 119,000.00